Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03900429 |
|---|---|
| Brief Title: | A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis (MAESTRO-NASH) |
| First Submitted : | March 26, 2019 |
| First Submitted that Met QC Criteria : | March 30, 2019 |
| First Posted : | April 3, 2019 |
| Certification/Extension First Submitted : | November 30, 2023 |
| Certification/Extension First Posted : | February 20, 2024 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | February 20, 2024 |